{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:39:23Z","timestamp":1793741963676,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.prostaglandins.2005.10.004","type":"journal-article","created":{"date-parts":[[2005,12,28]],"date-time":"2005-12-28T15:03:58Z","timestamp":1135782238000},"page":"84-92","source":"Crossref","is-referenced-by-count":94,"title":["Lipoxin biosynthesis in inflammatory bowel disease"],"prefix":"10.1016","volume":"79","author":[{"given":"Martin J.","family":"Mangino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Brounts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2005.10.004_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1098-3597(02)90005-0","article-title":"Inflammatory bowel disease","volume":"4","author":"Knigge","year":"2002","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib2","first-page":"81","article-title":"The state of the art in the management of inflammatory bowel disease","volume":"3","author":"Hanauer","year":"2003","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib3","article-title":"Pathogenesis of inflammatory bowel disease","volume":"16","author":"Stucchi","year":"1999"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.mn.7800095","article-title":"Immunological basis of inflammatory bowel disease: role of the microcirculation","volume":"8","author":"Laroux","year":"2001","journal-title":"Microcirculation"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4615-0193-0_35","article-title":"Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins","volume":"507","author":"Gewirtz","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0090-6980(02)00047-3","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution","volume":"68\u201369","author":"Serhan","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI7016","article-title":"Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion","volume":"104","author":"Chiang","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib9","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-19","article-title":"Formation of endogenous \u201cantiinflammatory\u201d lipid mediators by transcellular biosynthesis. Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability","volume":"161","author":"Serhan","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1100\/tsw.2002.81","article-title":"Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins","volume":"2","author":"Serhan","year":"2002","journal-title":"Sci World J"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib11","first-page":"G299","article-title":"Mucosal arachidonate metabolism and intestinal ischemia-reperfusion injury","volume":"257","author":"Mangino","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.191.7.1197","article-title":"Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation","volume":"191","author":"Chiang","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bjp.0705220","article-title":"A novel rat lipoxin A4 receptor that is conserved in structure and function","volume":"139","author":"Chiang","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.180.1.253","article-title":"Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor","volume":"180","author":"Fiore","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.187.8.1285","article-title":"Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release","volume":"187","author":"Gronert","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib16","doi-asserted-by":"crossref","first-page":"C888","DOI":"10.1152\/ajpcell.00507.2001","article-title":"Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium","volume":"284","author":"Kucharzik","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib17","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.4049\/jimmunol.168.10.5260","article-title":"Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis","volume":"168","author":"Gewirtz","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib18","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.4049\/jimmunol.170.12.6266","article-title":"Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells","volume":"170","author":"Ariel","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib19","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1073\/pnas.202296999","article-title":"Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes","volume":"99","author":"Jozsef","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/gast.2003.50154","article-title":"Lipoxins: pro-resolution lipid mediators in intestinal inflammation","volume":"124","author":"Goh","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib21","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1172\/JCI1339","article-title":"Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs","volume":"101","author":"Gewirtz","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib22","series-title":"Ernst Schering Res Found Workshop","first-page":"187","article-title":"Lipoxin-stable analogs: potential therapeutic downregulators of intestinal inflammation","author":"Gewirtz","year":"2000"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1381612805666230109194856","article-title":"15-Lipoxygenase and its inhibition: a novel therapeutic target for vascular disease","volume":"5","author":"Cornicelli","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjp.0701007","article-title":"Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties","volume":"120","author":"Sendobry","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib25","doi-asserted-by":"crossref","first-page":"23679","DOI":"10.1074\/jbc.274.34.23679","article-title":"Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate","volume":"274","author":"Brash","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1358\/dot.1998.34.1.485200","article-title":"Soluble mediators and the interaction of drugs in IBD","volume":"34","author":"Rask-Madsen","year":"1998","journal-title":"Drugs Today (Barc)"},{"issue":"Suppl.","key":"10.1016\/j.prostaglandins.2005.10.004_bib27","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1007\/BF02637086","article-title":"Quantification of distinct molecular species of platelet activating factor in ulcerative colitis","volume":"31","author":"Thyssen","year":"1996","journal-title":"Lipids"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00054725-200209000-00006","article-title":"Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice","volume":"8","author":"Mahler","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib29","doi-asserted-by":"crossref","first-page":"15736","DOI":"10.1073\/pnas.0404722101","article-title":"A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction","volume":"101","author":"Fiorucci","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.bi.55.070186.000441","article-title":"Arachidonic acid metabolism","volume":"55","author":"Needleman","year":"1986","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1006\/cryo.1996.0040","article-title":"Arachidonic acid metabolism in intestinal hypothermic preservation injury","volume":"33","author":"Mangino","year":"1996","journal-title":"Cryobiology"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib32","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/01.TP.0000062541.10466.16","article-title":"The effects of donor brain death on renal function and arachidonic acid metabolism in a large animal model of hypothermic preservation injury","volume":"75","author":"Mangino","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4615-4793-8_42","article-title":"Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability","volume":"469","author":"Serhan","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jat.2550100114","article-title":"Acetylation of 5-aminosalicylate by hamster colon arylamine N-acetyltransferase","volume":"10","author":"Tucker","year":"1990","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.prostaglandins.2005.10.004_bib35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF03401642","article-title":"Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation","volume":"2","author":"Claria","year":"1996","journal-title":"Mol Med"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882305001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882305001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T01:04:33Z","timestamp":1683335073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882305001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1098882305001425"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2005.10.004","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}